Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Itaru Hashimoto

Showing results (71-80 of 128) with videos related to

Pageof 13
Sort By:
In Vivo (Athens, Greece)|April 28, 2025
Preoperative Anemia Is an Independent Prognostic Factor for Esophageal Cancer Patients Who Receive Curative TreatmentKiyoko Shimada, Toru Aoyama, Itaru Hashimoto, et al.
Anticancer Research|April 30, 2022
The Systemic Inflammation Score Is an Independent Prognostic Factor for Esophageal Cancer Patients who Receive Curative TreatmentToru Aoyama, Mihwa Ju, Keisuke Komori, et al.
Anticancer Research|March 4, 2025
The CONUT Score Can Predict the Prognosis of Gastric Cancer Patients After Curative TreatmentRyuki Esashi, Toru Aoyama, Sosuke Yamamoto, et al.
Oncology Letters|August 8, 2024
Prognostic value of computed tomography‑derived skeletal muscle index and radiodensity in patients with gastric cancer after curative gastrectomyItaru Hashimoto, Keisuke Komori, Yukio Maezawa, et al.
In Vivo (Athens, Greece)|June 27, 2024
The Systemic Immune-inflammation Index Is an Independent Prognostic Factor for Gastric Cancer Patients Who Receive Curative TreatmentToru Aoyama, Yukio Maezawa, Itaru Hashimoto, et al.
Anticancer Research|January 25, 2023
Clinical Course of Vitamin B12 Deficiency and Associated Risk Factors in Patients After Total Gastrectomy for Gastric CancerToru Aoyama, Kentaro Hara, Yukio Maezawa, et al.
In Vivo (Athens, Greece)|June 27, 2024
Comparison of the Dietary Intake After Gastrectomy Between Male and Female Patients With Gastric CancerJunya Morita, Toru Aoyama, Masato Nakazono, et al.
In Vivo (Athens, Greece)|February 28, 2024
The Clinical Benefit of the Modified Neutrophil-Platelet Score as a Surrogate Prognostic Marker in Patients With Resectable Gastric CancerKazuki Otani, Toru Aoyama, Yukio Maezawa, et al.
Journal of Gastrointestinal Cancer|October 27, 2023
The Clinical Impact of Change in the Neutrophil to Lymphocyte Ratio During the Perioperative Period in Gastric Cancer Patients Who Receive Curative GastrectomyToru Aoyama, Itaru Hashimoto, Yukio Maezawa, et al.
Anticancer Research|January 2, 2020
The Impact of Intraoperative Blood Loss on the Long-term Prognosis after Curative Resection for Borrmann Type IV Gastric Cancer: A Retrospective Multicenter StudyHiroshi Tamagawa, Toru Aoyama, Kazuki Kano, et al.
Pageof 13

Showing results (71-80 of 128) with videos related to

Sort By:
Pageof 13
In Vivo (Athens, Greece)|April 28, 2025
Preoperative Anemia Is an Independent Prognostic Factor for Esophageal Cancer Patients Who Receive Curative TreatmentKiyoko Shimada, Toru Aoyama, Itaru Hashimoto, et al.
Anticancer Research|April 30, 2022
The Systemic Inflammation Score Is an Independent Prognostic Factor for Esophageal Cancer Patients who Receive Curative TreatmentToru Aoyama, Mihwa Ju, Keisuke Komori, et al.
Anticancer Research|March 4, 2025
The CONUT Score Can Predict the Prognosis of Gastric Cancer Patients After Curative TreatmentRyuki Esashi, Toru Aoyama, Sosuke Yamamoto, et al.
Oncology Letters|August 8, 2024
Prognostic value of computed tomography‑derived skeletal muscle index and radiodensity in patients with gastric cancer after curative gastrectomyItaru Hashimoto, Keisuke Komori, Yukio Maezawa, et al.
In Vivo (Athens, Greece)|June 27, 2024
The Systemic Immune-inflammation Index Is an Independent Prognostic Factor for Gastric Cancer Patients Who Receive Curative TreatmentToru Aoyama, Yukio Maezawa, Itaru Hashimoto, et al.
Anticancer Research|January 25, 2023
Clinical Course of Vitamin B12 Deficiency and Associated Risk Factors in Patients After Total Gastrectomy for Gastric CancerToru Aoyama, Kentaro Hara, Yukio Maezawa, et al.
In Vivo (Athens, Greece)|June 27, 2024
Comparison of the Dietary Intake After Gastrectomy Between Male and Female Patients With Gastric CancerJunya Morita, Toru Aoyama, Masato Nakazono, et al.
In Vivo (Athens, Greece)|February 28, 2024
The Clinical Benefit of the Modified Neutrophil-Platelet Score as a Surrogate Prognostic Marker in Patients With Resectable Gastric CancerKazuki Otani, Toru Aoyama, Yukio Maezawa, et al.
Journal of Gastrointestinal Cancer|October 27, 2023
The Clinical Impact of Change in the Neutrophil to Lymphocyte Ratio During the Perioperative Period in Gastric Cancer Patients Who Receive Curative GastrectomyToru Aoyama, Itaru Hashimoto, Yukio Maezawa, et al.
Anticancer Research|January 2, 2020
The Impact of Intraoperative Blood Loss on the Long-term Prognosis after Curative Resection for Borrmann Type IV Gastric Cancer: A Retrospective Multicenter StudyHiroshi Tamagawa, Toru Aoyama, Kazuki Kano, et al.
Pageof 13